Brief: Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037
21/10/2019 12:14
Oct 21 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS ANNOUNCES NEW U.S. PATENT FOR
TILSOTOLIMOD
THROUGH SEPTEMBER 2037
Source text for Eikon: ID:nGNX9y7Q2c
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary